Pleiotropic effects of coat colour-associated mutations in humans, mice and other mammals

Seminars in Cell and Developmental Biology

Volumn 24, Issue 6-7, 2013, Pages 576-586

  Reissmann, Monika ^a   Ludwig, Arne ^b  

^a HUMBOLDT UNIVERSITY   (Germany)

^b LEIBNIZ INSTITUTE FOR ZOO AND WILDLIFE RESEARCH   (Germany)

Author keywords

Albino; Coat colour gene; Disorder; Epistasis; Fitness; Lethal; Leucism; Melanoma; Pleiotropy; Reproduction; Tameness

Indexed keywords

ADENOSYLHOMOCYSTEINASE; ATTRACTIN; ENDOTHELIN 3; MELANOCORTIN 1 RECEPTOR; MELANOCORTIN RECEPTOR; MICROPHTHALMIA ASSOCIATED TRANSCRIPTION FACTOR; MYOSIN VA; TYROSINASE RELATED PROTEIN 1;

ARTIFICIAL SELECTION; BEHAVIOR CHANGE; BLEEDING TENDENCY; CANCER RISK; CATTLE DISEASE; CHEDIAK HIGASHI SYNDROME; DEPIGMENTATION; DOMESTIC ANIMAL; DOMESTIC SPECIES; DOMESTICATION; DWARFISM; ERYTHROPHAGOCYTOSIS; EYE COLOR; EYE DISEASE; EYE MALFORMATION; FELINE PANLEUKOPENIA; FOUNDER EFFECT; FRAMESHIFT MUTATION; GAMETOGENESIS; GENE ACTIVITY; GENE FUNCTION; GENE IDENTIFICATION; GENE MUTATION; GRISCELLI SYNDROME; HAPPY PUPPET SYNDROME; HEARING IMPAIRMENT; HEMATOPOIESIS; HEMOPHAGOCYTIC SYNDROME; HETEROZYGOTE; HETEROZYGOTE ADVANTAGE; HIRSCHSPRUNG DISEASE; HORSE; HUMAN; HYPERGLYCEMIA; HYPERINSULINEMIA; HYPERPLASIA; HYPERURICEMIA; HYPERURICOSURIA; LETHALITY; LIVER DYSFUNCTION; LUNG FIBROSIS; MACROCYTIC ANEMIA; MATE CHOICE; MEGACOLON; MELANOCYTE; MELANOGENESIS; MELANOMA; MELANOSOME; MICROPHTHALMIA; MOLECULAR PHYLOGENY; MOUSE STRAIN; NIGHT BLINDNESS; NONHUMAN; NYSTAGMUS; OBESITY; OCULOCUTANEOUS ALBINISM; ONCOGENE RAS; OVARY FOLLICLE; OVARY FOLLICLE DEVELOPMENT; PERCEPTION DEAFNESS; PEROMYSCUS; PHENOTYPE; PIEBALDISM; PIGMENT CELL; PIGMENT EPITHELIUM; PLEIOTROPY; PRADER WILLI SYNDROME; QUANTITATIVE TRAIT LOCUS; REVIEW; SENSE ORGAN; SKIN CANCER; SKIN PIGMENTATION; STRIA VASCULARIS; SYRIAN HAMSTER; THROMBOCYTE DISORDER; TRANSDERMAL PATCH; TUNICA ALBUGINEA; UNDERWEIGHT; UNITED STATES; VIRUS ONCOGENE; VISUAL ACUITY; VITILIGO; VULPES VULPES; WAARDENBURG SYNDROME; WILD ANIMAL;

MAMMALIA; MUS;

AGOUTI SIGNALLING PROTEIN; ALBINO; ALPHA-MELANOCYTE-STIMULATING HORMONE; ANGELMAN SYNDROME; AS; ASIP; ATRN; ATTRACTIN (MAHOGANY); BIOGENESIS OF LYSOSOMAL ORGANELLES COMPLEX; BLOC; CANINE CONGENITAL SENSORINEURAL DEAFNESS; CCSD; CHEDIAK-HIGASHI SYNDROME; CHS; COAT COLOUR GENE; CONGENITAL SENSORINEURAL DEAFNESS; CONGENITAL STATIONARY NIGHT BLINDNESS; CSD; CSNB; DISORDER; EDN3; EDNRB; ENDOTHELIN 3; ENDOTHELIN RECEPTOR TYPE B; EPISTASIS; FITNESS; GRISCELLI SYNDROME (TYPE 1 OR 2); GS; HERMANSKY-PUDLAK SYNDROME WITH DIFFERENT TYPES; HIRSCHSPRUNG DISEASE; HPS; HSCR; IPE; IRIS PIGMENT EPITHELIUM; KIT; KIT LIGAND (STEEL FACTOR); KITLG; LAVENDER FOAL SYNDROME; LETHAL; LEUCISM; LFS; LYSOSOMAL TRAFFICKING REGULATOR; LYST; MAHOGUNIN RING FINGER 1 (E3 UBIQUITIN PROTEIN LIGASE); MC1R; MCOA; MCOLN3; MELANOCORTIN 1 RECEPTOR; MELANOMA; MGRN1; MICROPHTHALMIA-ASSOCIATED TRANSCRIPTION FACTOR; MITF; MUCOLIPIN 3 (TRPML3); MULTIPLE CONGENITAL OCULAR ANOMALIES; MYO5A; MYOSIN VA (HEAVY CHAIN 12, MYOXIN); OA; OCA; OCA2; OCULAR ALBINISM; OCULOCUTANEOUS ALBINISM II (PINK-EYE DILUTION HOMOLOG); OCULOCUTANEOUS ALBINISM TYPE 1-4; OLWS; OSTEOPETROSIS ASSOCIATED TRANSMEMBRANE PROTEIN 1 (GREY LETHAL OSTEOPETROSIS); OSTM1; OVERO LETHAL WHITE SYNDROME; PAIRED BOX 3; PAX3; PLEIOTROPY; PMEL; PRADER-WILLI SYNDROME; PREMELANOSOME PROTEIN (PMEL17, SILV); PWS; RAB27A; RAB27A MEMBER RAS ONCOGENE FAMILY; RAB38; RAB38 MEMBER RAS ONCOGENE FAMILY; REPRODUCTION; RETINAL PIGMENTED EPITHELIUM; RPE; SLC24A5; SLC2A9; SLC45A2; SNAI2; SNAIL HOMOLOG 2 (DROSOPHILA), (SLUG), SOX10, SRY (SEX DETERMINING REGION Y)-BOX 10; SOLUTE CARRIER FAMILY 2 (FACILITATED GLUCOSE TRANSPORTER), MEMBER 9; SOLUTE CARRIER FAMILY 24, MEMBER 5; SOLUTE CARRIER FAMILY 45, MEMBER 2, MATP; STX17; SYNTAXIN 17; TAMENESS; TRANSIENT RECEPTOR POTENTIAL CATION CHANNEL, SUBFAMILY M, MEMBER 1 (MELASTATIN-1); TRPM1; TYR; TYROSINASE, TYRP1, TYROSINASE-RELATED PROTEIN 1; V-KIT HARDY-ZUCKERMAN 4 FELINE SARCOMA VIRAL ONCOGENE HOMOLOG, TYROSINE KINASE RECEPTOR (C-KIT); WAARDENBURG SYNDROME (TYPE 1, TYPE 2 COMBINED WITH TIETZ SYNDROME TYPE 3 KLEIN-WAARDENBURG SYNDROME, TYPE 4 WAARDENBURG-SHAH SYNDROME); WS; ΑMSH;

ALLELES; ANIMALS; COLOR; GENETIC PLEIOTROPY; HAIR COLOR; HUMANS; MICE; MUTATION;

EID: 84883299174     PISSN: 10849521     EISSN: 10963634     Source Type: Journal    
DOI: 10.1016/j.semcdb.2013.03.014     Document Type: Review

References (180)

1. Hofreiter M., Schoneberg T. The genetic and evolutionary basis of colour variation in vertebrates. Cellular and Molecular Life Sciences 2010, 67:2591-2603.
2. Cieslak M., Reissmann M., Hofreiter M., Ludwig A. Colours of domestication. Biological reviews of the Cambridge Philosophical Society 2011, 86:885-899.
3. Hubbard J.K., Uy J.A., Hauber M.E., Hoekstra H.E., Safran R.J. Vertebrate pigmentation: from underlying genes to adaptive function. Trends in Genetics 2010, 26:231-239.
4. Steingrimsson E., Copeland N.G., Jenkins N.A. Mouse coat color mutations: from fancy mice to functional genomics. Developmental Dynamics 2006, 235:2401-2411.
5. Bellone R.R. Pleiotropic effects of pigmentation genes in horses. Animal Genetics 2010, 41(Suppl. 2):100-110.
6. Webb A.A., Cullen C.L. Coat color and coat color pattern-related neurologic and neuro-ophthalmic diseases. The Canadian Veterinary Journal La revue Veterinaire Canadienne 2010, 51:653-657.
7. Nischler C., Michael R., Wintersteller C., Marvan P., van Rijn L.J., Coppens J.E., et al. Iris color and visual functions. Graefe's archive for clinical and experimental ophthalmology=Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie 2013, 251:195-202.
8. Laukner A. Coat color in dogs 2: clinical significance. Tierarztliche Praxis Ausgabe K, Kleintiere/Heimtiere 1998, 26:124-128.
9. Dessinioti C., Stratigos A.J., Rigopoulos D., Katsambas A.D. A review of genetic disorders of hypopigmentation: lessons learned from the biology of melanocytes. Experimental Dermatology 2009, 18:741-749.
10. Sturm R.A., Larsson M. Genetics of human iris colour and patterns. Pigment Cell & Melanoma Research 2009, 22:544-562.
11. Oetting W.S., Brilliant M.H., King R.A. The clinical spectrum of albinism in humans. Molecular Medicine Today 1996, 2:330-335.
12. Imesch P.D., Wallow I.H., Albert D.M. The color of the human eye: a review of morphologic correlates and of some conditions that affect iridial pigmentation. Survey of Ophthalmology 1997, 41(Suppl. 2):S117-S123.
13. Anderson M.G., Hawes N.L., Trantow C.M., Chang B., John S.W. Iris phenotypes and pigment dispersion caused by genes influencing pigmentation. Pigment Cell & Melanoma Research 2008, 21:565-578.
14. Oetting W.S. The tyrosinase gene and oculocutaneous albinism type 1 (OCA1): a model for understanding the molecular biology of melanin formation. Pigment Cell Research/Sponsored by the European Society for Pigment Cell Research and the International Pigment Cell Society 2000, 13:320-325.
15. Rachel R.A., Mason C.A., Beermann F. Influence of tyrosinase levels on pigment accumulation in the retinal pigment epithelium and on the uncrossed retinal projection. Pigment Cell Research/Sponsored by the European Society for Pigment Cell Research and the International Pigment Cell Society 2002, 15:273-281.
16. Gargiulo A., Bonetti C., Montefusco S., Neglia S., Di Vicino U., Marrocco E., et al. AAV-mediated tyrosinase gene transfer restores melanogenesis and retinal function in a model of oculo-cutaneous albinism type I (OCA1). Molecular Therapy 2009, 17:1347-1354.
17. Witkop J.C.J., Quevedo J.W.C., Fitzpatrick T.B. Albinism. The metabolic basis of inherited disease 1978, 283-316. McGraw-Hill, New York. 5th ed. J.B. Stanbury, J.B. Wyngaarden, D.S. Frerickson (Eds.).
18. Gronskov K., Ek J., Brondum-Nielsen K. Oculocutaneous albinism. Orphanet Journal of Rare Diseases 2007, 2:43.
19. Sengupta M., Chaki M., Arti N., Ray K. SLC45A2 variations in Indian oculocutaneous albinism patients. Molecular Vision 2007, 13:1406-1411.
20. Li H.Y., Duan H.L., Zheng H. A new form of Oculocutaneous albinism, OCA4. Yi chuan=Hereditas/Zhongguo yi chuan xue hui bian ji 2006, 28:1149-1152.
21. Inagaki K., Suzuki T., Ito S., Suzuki N., Adachi K., Okuyama T., et al. Oculocutaneous albinism type 4: six novel mutations in the membrane-associated transporter protein gene and their phenotypes. Pigment Cell Research/Sponsored by the European Society for Pigment Cell Research and the International Pigment Cell Society 2006, 19:451-453.
22. Imes D.L., Geary L.A., Grahn R.A., Lyons L.A. Albinism in the domestic cat (Felis catus) is associated with a tyrosinase (TYR) mutation. Animal Genetics 2006, 37:175-178.
23. Lyons L.A., Imes D.L., Rah H.C., Grahn R.A. Tyrosinase mutations associated with Siamese and Burmese patterns in the domestic cat (Felis catus). Animal Genetics 2005, 36:119-126.
24. Benkel B.F., Rouvinen-Watt K., Farid H., Anistoroaei R. Molecular characterization of the Himalayan mink. Mammalian Genome 2009, 20:256-259.
25. Anistoroaei R., Fredholm M., Christensen K., Leeb T. Albinism in the American mink (Neovison vison) is associated with a tyrosinase nonsense mutation. Animal Genetics 2008, 39:645-648.
26. Schmutz S.M., Berryere T.G. Genes affecting coat colour and pattern in domestic dogs: a review. Animal Genetics 2007, 38:539-549.
27. Grahn B.H., Pinard C., Archer S., Bellone R., Forsyth G., Sandmeyer L.S. Congenital ocular anomalies in purebred and crossbred Rocky and Kentucky Mountain horses in Canada. The Canadian Veterinary Journal La revue Veterinaire Canadienne 2008, 49:675-681.
28. Komaromy A.M., Rowlan J.S., La Croix N.C., Mangan B.G. Equine Multiple Congenital Ocular Anomalies (MCOA) syndrome in PMEL17 (Silver) mutant ponies: five cases. Veterinary Ophthalmology 2011, 14:313-320.
29. Andersson L.S., Axelsson J., Dubielzig R.R., Lindgren G., Ekesten B. Multiple congenital ocular anomalies in Icelandic horses. BMC Veterinary Research 2011, 7:21.
30. Vogel P., Read R.W., Vance R.B., Platt K.A., Troughton K., Rice D.S. Ocular albinism and hypopigmentation defects in Slc24a5-/- mice. Veterinary Pathology 2008, 45:264-279.
31. Brooks B.P., Larson D.M., Chan C.C., Kjellstrom S., Smith R.S., Crawford M.A., et al. Analysis of ocular hypopigmentation in Rab38cht/cht mice. Investigative Ophthalmology & Visual Science 2007, 48:3905-3913.
32. Fridman C., Hosomi N., Varela M.C., Souza A.H., Fukai K., Koiffmann C.P. Angelman syndrome associated with oculocutaneous albinism due to an intragenic deletion of the P gene. American Journal of Medical Genetics Part A 2003, 119A:180-183.
33. Kraoua L., Chaabouni M., Ewers E., Chelly I., Ouertani I., Ben Jemaa L., et al. Hexasomy of the Prader-Willi/Angelman critical region, including the OCA2 gene, in a patient with pigmentary dysplasia: case report. European Journal of Medical Genetics 2011, 54:e446-e450.
34. Sakazume S., Ohashi H., Sasaki Y., Harada N., Nakanishi K., Sato H., et al. Spread of X-chromosome inactivation into chromosome 15 is associated with Prader-Willi syndrome phenotype in a boy with a t(X;15)(p21.1;q11.2) translocation. Human Genetics 2012, 131:121-130.
35. Strain G.M. Congenital deafness and its recognition. The Veterinary Clinics of North America Small Animal Practice 1999, 29:895-907. vi.
36. Clark L.A., Wahl J.M., Rees C.A., Murphy K.E. Retrotransposon insertion in SILV is responsible for merle patterning of the domestic dog. Proceedings of the National Academy of Sciences of the United States of America 2006, 103:1376-1381.
37. Platt S., Freeman J., di Stefani A., Wieczorek L., Henley W. Prevalence of unilateral and bilateral deafness in border collies and association with phenotype. Journal of Veterinary Internal Medicine/American College of Veterinary Internal Medicine 2006, 20:1355-1362.
38. Sommerlad S., McRae A.F., McDonald B., Johnstone I., Cuttell L., Seddon J.M., et al. Congenital sensorineural deafness in Australian stumpy-tail cattle dogs is an autosomal recessive trait that maps to CFA10. PloS ONE 2010, 5:e13364.
39. Bauer G.L., Praetorius C., Bergsteinsdottir K., Hallsson J.H., Gisladottir B.K., Schepsky A., et al. The role of MITF phosphorylation sites during coat color and eye development in mice analyzed by bacterial artificial chromosome transgene rescue. Genetics 2009, 183:581-594.
40. Tachibana M., Kobayashi Y., Matsushima Y. Mouse models for four types of Waardenburg syndrome. Pigment Cell Research/Sponsored by the European Society for Pigment Cell Research and the International Pigment Cell Society 2003, 16:448-454.
41. Hofstra R.M., Osinga J., Tan-Sindhunata G., Wu Y., Kamsteeg E.J., Stulp R.P., et al. A homozygous mutation in the endothelin-3 gene associated with a combined Waardenburg type 2 and Hirschsprung phenotype (Shah-Waardenburg syndrome). Nature Genetics 1996, 12:445-447.
42. Haddad N.M., Ente D., Chouery E., Jalkh N., Mehawej C., Khoueir Z., et al. Molecular study of three Lebanese and Syrian patients with Waardenburg syndrome and report of novel mutations in the EDNRB and MITF genes. Molecular Syndromology 2011, 1:169-175.
43. Amiel J., Attie T., Jan D., Pelet A., Edery P., Bidaud C., et al. Heterozygous endothelin receptor B (EDNRB) mutations in isolated Hirschsprung disease. Human Molecular Genetics 1996, 5:355-357.
44. Smith S.D., Kelley P.M., Kenyon J.B., Hoover D. Tietz syndrome (hypopigmentation/deafness) caused by mutation of MITF. Journal of Medical Genetics 2000, 37:446-448.
45. Metallinos D.L., Bowling A.T., Rine J. A missense mutation in the endothelin-B receptor gene is associated with Lethal White Foal Syndrome: an equine version of Hirschsprung disease. Mammalian Genome 1998, 9:426-431.
46. Santschi E.M., Vrotsos P.D., Purdy A.K., Mickelson J.R. Incidence of the endothelin receptor B mutation that causes lethal white foal syndrome in white-patterned horses. American Journal of Veterinary Research 2001, 62:97-103.
47. Santschi E.M., Purdy A.K., Valberg S.J., Vrotsos P.D., Kaese H., Mickelson J.R. Endothelin receptor B polymorphism associated with lethal white foal syndrome in horses. Mammalian Genome 1998, 9:306-309.
48. Hosoda K., Hammer R.E., Richardson J.A., Baynash A.G., Cheung J.C., Giaid A., et al. Targeted and natural (piebald-lethal) mutations of endothelin-B receptor gene produce megacolon associated with spotted coat color in mice. Cell 1994, 79:1267-1276.
49. Baynash A.G., Hosoda K., Giaid A., Richardson J.A., Emoto N., Hammer R.E., et al. Interaction of endothelin-3 with endothelin-B receptor is essential for development of epidermal melanocytes and enteric neurons. Cell 1994, 79:1277-1285.
50. Gariepy C.E., Williams S.C., Richardson J.A., Hammer R.E., Yanagisawa M. Transgenic expression of the endothelin-B receptor prevents congenital intestinal aganglionosis in a rat model of Hirschsprung disease. The Journal of Clinical Investigation 1998, 102:1092-1101.
51. Gariepy C.E., Cass D.T., Yanagisawa M. Null mutation of endothelin receptor type B gene in spotting lethal rats causes aganglionic megacolon and white coat color. Proceedings of the National Academy of Sciences of the United States of America 1996, 93:867-872.
52. Kunieda T., Kumagai T., Tsuji T., Ozaki T., Karaki H., Ikadai H. A mutation in endothelin-B receptor gene causes myenteric aganglionosis and coat color spotting in rats. DNA Research 1996, 3:101-105.
53. Tuysuz B., Collin A., Arapoglu M., Suyugul N. Clinical variability of Waardenburg-Shah syndrome in patients with proximal 13q deletion syndrome including the endothelin-B receptor locus. American Journal of Medical Genetics Part A 2009, 149A:2290-2295.
54. Britsch S., Goerich D.E., Riethmacher D., Peirano R.I., Rossner M., Nave K.A., et al. The transcription factor Sox10 is a key regulator of peripheral glial development. Genes & Development 2001, 15:66-78.
55. Bondurand N., Dastot-Le Moal F., Stanchina L., Collot N., Baral V., Marlin S., et al. Deletions at the SOX10 gene locus cause Waardenburg syndrome types 2 and 4. American Journal of Human Genetics 2007, 81:1169-1185.
56. Rothschild M.F., Van Cleave P.S., Glenn K.L., Carlstrom L.P., Ellinwood N.M. Association of MITF with white spotting in Beagle crosses and Newfoundland dogs. Animal Genetics 2006, 37:606-607.
57. Stritzel S., Wohlke A., Distl O. A role of the microphthalmia-associated transcription factor in congenital sensorineural deafness and eye pigmentation in Dalmatian dogs. Journal of Animal Breeding and Genetics=Zeitschrift fur Tierzuchtung und Zuchtungsbiologie 2009, 126:59-62.
58. Magdesian K.G., Williams D.C., Aleman M., Lecouteur R.A., Madigan J.E. Evaluation of deafness in American Paint Horses by phenotype, brainstem auditory-evoked responses, and endothelin receptor B genotype. Journal of the American Veterinary Medical Association 2009, 235:1204-1211.
59. Hauswirth R., Haase B., Blatter M., Brooks S.A., Burger D., Drogemuller C., et al. Mutations in MITF and PAX3 cause "splashed white" and other white spotting phenotypes in horses. PLoS Genetics 2012, 8:e1002653.
60. Hozumi H., Takeda K., Yoshida-Amano Y., Takemoto Y., Kusumi R., Fukuzaki-Dohi U., et al. Impaired development of melanoblasts in the black-eyed white Mitf(mi-bw) mouse, a model for auditory-pigmentary disorders. Genes to Cells 2012, 17:494-508.
61. Bergsma D.R., Brown K.S. White fur, blue eyes, and deafness in the domestic cat. The Journal of Heredity 1971, 62:171-185.
62. Cvejic D., Steinberg T.A., Kent M.S., Fischer A. Unilateral and bilateral congenital sensorineural deafness in client-owned pure-breed white cats. Journal of Veterinary Internal Medicine 2009, 23:392-395.
63. Asher J.H., James S.C. The primary ultrastructural defect caused by anophthalmic white (Wh) in the Syrian hamster. Proceedings of the National Academy of Sciences of the United States of America 1982, 79:4371-4375.
64. Famula T.R., Cargill E.J., Strain G.M. Heritability and complex segregation analysis of deafness in Jack Russell Terriers. BMC Veterinary Research 2007, 3:31.
65. Menasche G., Ho C.H., Sanal O., Feldmann J., Tezcan I., Ersoy F., et al. Griscelli syndrome restricted to hypopigmentation results from a melanophilin defect (GS3) or a MYO5A F-exon deletion (GS1). The Journal of Clinical Investigation 2003, 112:450-456.
66. Brooks S.A., Gabreski N., Miller D., Brisbin A., Brown H.E., Streeter C., et al. Whole-genome SNP association in the horse: identification of a deletion in myosin Va responsible for Lavender Foal syndrome. PLoS Genetics 2010, 6:e1000909.
67. Gabreski N.A., Haase B., Armstrong C.D., Distl O., Brooks S.A. Investigation of allele frequencies for Lavender foal syndrome in the horse. Animal Genetics 2012.
68. Sandmeyer L.S., Bellone R.R., Archer S., Bauer B.S., Nelson J., Forsyth G., et al. Congenital stationary night blindness is associated with the leopard complex in the Miniature Horse. Veterinary Ophthalmology 2012, 15:18-22.
69. Sandmeyer L.S., Breaux C.B., Archer S., Grahn B.H. Clinical and electroretinographic characteristics of congenital stationary night blindness in the Appaloosa and the association with the leopard complex. Veterinary Ophthalmology 2007, 10:368-375.
70. Bellone R.R., Forsyth G., Leeb T., Archer S., Sigurdsson S., Imsland F., et al. Fine-mapping and mutation analysis of TRPM1: a candidate gene for leopard complex (LP) spotting and congenital stationary night blindness in horses. Briefings in Functional Genomics 2010, 9:193-207.
71. Pruvost M., Bellone R., Benecke N., Sandoval-Castellanos E., Cieslak M., Kuznetsova T., et al. Genotypes of predomestic horses match phenotypes painted in Paleolithic works of cave art. Proceedings of the National Academy of Sciences of the United States of America 2011, 108:18626-18630.
72. Hedrick P.W. What is the evidence for heterozygote advantage selection?. Trends in Ecology & Evolution 2012, 27:698-704.
73. Besmer P., Manova K., Duttlinger R., Huang E.J., Packer A., Gyssler C., et al. The kit-ligand (steel factor) and its receptor c-kit/W: pleiotropic roles in gametogenesis and melanogenesis. Development. Supplement 1993, 125-137.
74. Fleischman R.A. From white spots to stem cells: the role of the Kit receptor in mammalian development. Trends in Genetics 1993, 9:285-290.
75. Ohta H., Tohda A., Nishimune Y. Proliferation and differentiation of spermatogonial stem cells in the w/wv mutant mouse testis. Biology of Reproduction 2003, 69:1815-1821.
76. Kubota H., Avarbock M.R., Schmidt J.A., Brinster R.L. Spermatogonial stem cells derived from infertile Wv/Wv mice self-renew in vitro and generate progeny following transplantation. Biology of Reproduction 2009, 81:293-301.
77. Geissler E.N., McFarland E.C., Russell E.S. Analysis of pleiotropism at the dominant white-spotting (W) locus of the house mouse: a description of ten new W alleles. Genetics 1981, 97:337-361.
78. Broxmeyer H.E., Maze R., Miyazawa K., Carow C., Hendrie P.C., Cooper S., et al. The kit receptor and its ligand, steel factor, as regulators of hemopoiesis. Cancer Cells 1991, 3:480-487.
79. Ikuta K., Ingolia D.E., Friedman J., Heimfeld S., Weissman I.L. Mouse hematopoietic stem cells and the interaction of c-kit receptor and steel factor. International Journal of Cell Cloning 1991, 9:451-460.
80. Geissler E.N., Russell E.S. Analysis of the hematopoietic effects of new dominant spotting (W) mutations of the mouse. II. Effects on mast cell development. Experimental Hematology 1983, 11:461-466.
81. Moniruzzaman M., Sakamaki K., Akazawa Y., Miyano T. Oocyte growth and follicular development in KIT-deficient Fas-knockout mice. Reproduction 2007, 133:117-125.
82. Kuroda H., Terada N., Nakayama H., Matsumoto K., Kitamura Y. Infertility due to growth arrest of ovarian follicles in Sl/Slt mice. Developmental Biology 1988, 126:71-79.
83. Haase B., Brooks S.A., Schlumbaum A., Azor P.J., Bailey E., Alaeddine F., et al. Allelic heterogeneity at the equine KIT locus in dominant white (W) horses. PLoS Genetics 2007, 3:e195.
84. Haase B., Brooks S.A., Tozaki T., Burger D., Poncet P.A., Rieder S., et al. Seven novel KIT mutations in horses with white coat colour phenotypes. Animal Genetics 2009, 40:623-629.
85. Haase B., Obexer-Ruff G., Dolf G., Rieder S., Burger D., Poncet P.A., et al. Haematological parameters are normal in dominant white Franches-Montagnes horses carrying a KIT mutation. Veterinary Journal 2010, 184:315-317.
86. Marklund S., Moller M., Sandberg K., Andersson L. Close association between sequence polymorphism in the KIT gene and the roan coat color in horses. Mammalian Genome 1999, 10:283-288.
87. Hintz H.F., Van Vleck L.D. Lethal dominant roan in horses. The Journal of Heredity 1979, 70:145-146.
88. Sponenberg D.P., Harper H.T., Harper A.L. Direct evidence for linkage of roan and extension loci in Belgian horses. The Journal of Heredity 1984, 75:413-414.
89. Charlier C., Denys B., Belanche J.I., Coppieters W., Grobet L., Mni M., et al. Microsatellite mapping of the bovine roan locus: a major determinant of White Heifer disease. Mammalian Genome 1996, 7:138-142.
90. Rogers M.S., Boyartchuk V., Rohan R.M., Birsner A.E., Dietrich W.F., D'Amato R.J. The classical pink-eyed dilution mutation affects angiogenic responsiveness. PLoS ONE 2012, 7:e35237.
91. Hunt D.M., Johnson D.R. Abnormal spermiogenesis in two pink-eyed sterile mutants in the mouse. Journal of Embryology and Experimental Morphology 1971, 26:111-121.
92. Nixon C.W., Whitney R., Connelly M.E. Additional data on the dominant lethal gray in Syrian hamsters. The Journal of Heredity 1969, 60:74.
93. Henwood C., Henwood J., Robinson R. Dominant white spotting in the Chinese hamster. The Journal of Heredity 1987, 78:280.
94. Wada A., Tsudzuki M. Microphthalmia: a morphogenetic lethal mutation of the campbelli hamster (Phodopus campbelli). The Journal of Heredity 1998, 89:93-96.
95. Trut L.N. Early canid domestication: the farm-fox experiment. American Scientist 1999, 87:160-169.
96. Trut L.N., Ruvinsky A., Sampson J. The genetics of the dog, experimental studies in early canid domestication 2001, 15-41. CABI Publishing, New York. A. Ruvinsky, J. Sampson (Eds.).
97. Prasolova L.A., Os'kina I.N., Pliusnina I.Z., Trut L.N. Methyl-containing diet of mothers affects the AGOUTI gene expression in the offspring of rats with various behavioral types. Genetika 2009, 45:670-676.
98. Ludwig A., Pruvost M., Reissmann M., Benecke N., Brockmann G.A., Castanos P., et al. Coat color variation at the beginning of horse domestication. Science 2009, 324:485.
99. Keeler C., Mellinger T., Fromm E., Melanin Wade L. adrenalin and the legacy of fear. The Journal of Heredity 1970, 61:81-88.
100. Keeler C.E. Coat color, physique, and temperament. The Journal of Heredity 1947, 38:271-277.
101. Laukner A. Coat color in dogs. 1: Basics of coat color genesis. Tierarztliche Praxis Ausgabe K, Kleintiere/Heimtiere 1998, 26:49-54.
102. Hemmer H. Domestication - Improverishment of the Trait World 1983, Friedrich Vieweg & Sohn, Braunschweig/Wiesbaden.
103. Hayssen V., Gunawardhana S., Meyer J. The agouti coat-color locus may influence brain catecholamines: regional differences in norepinephrine and dopamine in the brains of two color-morphs of deermice (Peromyscus maniculatus). Comparative Biochemistry and Physiology 1994, 107C:51-55.
104. Hayssen V. Effects of the nonagouti coat-color allele on behavior of deer mice (Peromyscus maniculatus): a comparison with Norway rats (Rattus norvegicus). Journal of Comparative Psychology 1997, 111:419-423.
105. Farris E.J., Yeakel E.H. The susceptibility of albino and gray Norway rats to audiogenic seizures. Journal of Comparative Psychology 1943, 35:73-80.
106. Plonka P.M., Passeron T., Brenner M., Tobin D.J., Shibahara S., Thomas A., et al. What are melanocytes really doing all day long?. Experimental Dermatology 2009, 18:799-819.
107. Jannot A.S., Meziani R., Bertrand G., Gerard B., Descamps V., Archimbaud A., et al. Allele variations in the OCA2 gene (pink-eyed-dilution locus) are associated with genetic susceptibility to melanoma. European Journal of Human Genetics 2005, 13:913-920.
108. Maccioni L., Rachakonda P.S., Scherer D., Bermejo J.L., Planelles D., Requena C., et al. Variants at chromosome 20 (ASIP locus) and melanoma risk. International Journal of Cancer 2013, 132:42-54.
109. Ghiorzo P., Bonelli L., Pastorino L., Bruno W., Barile M., Andreotti V., et al. MC1R variation and melanoma risk in relation to host/clinical and environmental factors in CDKN2A positive and negative melanoma patients. Experimental Dermatology 2012, 21:718-720.
110. Quint K.D., van der Rhee J.I., Gruis N.A., Ter Huurne J.A., Wolterbeek R., van der Stoep N., et al. Melanocortin 1 receptor (MC1R) variants in high melanoma risk patients are associated with specific dermoscopic ABCD features. Acta Dermato-Venereologica 2012, 92:587-592.
111. Helsing P., Nymoen D.A., Rootwelt H., Vardal M., Akslen L.A., Molven A., et al. MC1R, ASIP, TYR, and TYRP1 gene variants in a population-based series of multiple primary melanomas. Genes, Chromosomes & Cancer 2012, 51:654-661.
112. Ibarrola-Villava M., Hu H.H., Guedj M., Fernandez L.P., Descamps V., Basset-Seguin N., et al. MC1R, SLC45A2 and TYR genetic variants involved in melanoma susceptibility in Southern European populations: results from a meta-analysis. European Journal of Cancer 2012, 48:2183-2191.
113. Fernandez L.P., Milne R.L., Pita G., Aviles J.A., Lazaro P., Benitez J., et al. SLC45A2: a novel malignant melanoma-associated gene. Human Mutation 2008, 29:1161-1167.
114. Ibarrola-Villava M., Fernandez L.P., Alonso S., Boyano M.D., Pena-Chilet M., Pita G., et al. A customized pigmentation SNP array identifies a novel SNP associated with melanoma predisposition in the SLC45A2 gene. PLoS ONE 2011, 6:e19271.
115. Rosengren Pielberg G., Golovko A., Sundstrom E., Curik I., Lennartsson J., Seltenhammer M.H., et al. A cis-acting regulatory mutation causes premature hair graying and susceptibility to melanoma in the horse. Nature Genetics 2008, 40:1004-1009.
116. Sundstrom E., Imsland F., Mikko S., Wade C., Sigurdsson S., Pielberg G.R., et al. Copy number expansion of the STX17 duplication in melanoma tissue from grey horses. BMC Genomics 2012, 13:365.
117. Sundstrom E., Komisarczuk A.Z., Jiang L., Golovko A., Navratilova P., Rinkwitz S., et al. Identification of a melanocyte-specific, microphthalmia-associated transcription factor-dependent regulatory element in the intronic duplication causing hair greying and melanoma in horses. Pigment Cell & Melanoma Research 2012, 25:28-36.
118. Chalhoub N., Benachenhou N., Rajapurohitam V., Pata M., Ferron M., Frattini A., et al. Grey-lethal mutation induces severe malignant autosomal recessive osteopetrosis in mouse and human. Nature Medicine 2003, 9:399-406.
119. Quarello P., Forni M., Barberis L., Defilippi C., Campagnoli M.F., Silvestro L., et al. Severe malignant osteopetrosis caused by a GL gene mutation. Journal of Bone and Mineral Research 2004, 19:1194-1199.
120. Berrier H.H., Robinson F.R., Reed T.H., Gray C.W. The white-tiger enigma. Veterinary Medicine, Small Animal Clinician 1975, 70:467-472.
121. Ridgway S.H. Reported causes of death of captive killer whales (Orcinus orca). Journal of Wildlife Diseases 1979, 15:99-104.
122. Collier L.L., King E.J., Prieur D.J. Tapetal degeneration in cats with Chediak-Higashi syndrome. Current Eye Research 1985, 4:767-773.
123. Collier L.L., Prieur D.J., King E.J. Ocular melanin pigmentation anomalies in cats, cattle, mink, and mice with Chediak-Higashi syndrome: histologic observations. Current Eye Research 1984, 3:1241-1251.
124. Nagle D.L., Karim M.A., Woolf E.A., Holmgren L., Bork P., Misumi D.J., et al. Identification and mutation analysis of the complete gene for Chediak-Higashi syndrome. Nature Genetics 1996, 14:307-311.
125. Callan M.B., Griot-Wenk M.E., Hackner S.G., Giger U. Persistent thrombopathy causing bleeding in 2 domestic shorthaired cats. Journal of Veterinary Internal Medicine/American College of Veterinary Internal Medicine 2000, 14:217-220.
126. Anistoroaei R., Krogh A.K., Christensen K. A frameshift mutation in the LYST gene is responsible for the Aleutian color and the associated Chediak-Higashi syndrome in American mink. Animal Genetics 2013, 44:178-183.
127. Uzenbaeva L.B., Kizhina A.G., Iliukha V.A., Tiutiunnik N.N. Morphology and cytochemistry of abnormal cytoplasmic granules in blood leukocytes in sapphire minks (cytological and cytochemical study). Morfologiia 2011, 140:60-64.
128. Uzenbaeva L.B., Trapezov O.V., Kizhina A.G., Iliukha V.A., Trapezova L.I., Tiutiunnik N.N. Effect of mutations affecting coat color on the blood lymphocyte structure in the American mink (Mustela vison Schreber, 1777). Genetika 2011, 47:87-94.
129. Introne W., Boissy R.E., Gahl W.A. Clinical, molecular, and cell biological aspects of Chediak-Higashi syndrome. Molecular Genetics and Metabolism 1999, 68:283-303.
130. Kunieda T., Nakagiri M., Takami M., Ide H., Ogawa H. Cloning of bovine LYST gene and identification of a missense mutation associated with Chediak-Higashi syndrome of cattle. Mammalian Genome 1999, 10:1146-1149.
131. Menasche G., Pastural E., Feldmann J., Certain S., Ersoy F., Dupuis S., et al. Mutations in RAB27A cause Griscelli syndrome associated with haemophagocytic syndrome. Nature Genetics 2000, 25:173-176.
132. Wilson S.M., Yip R., Swing D.A., O'Sullivan T.N., Zhang Y., Novak E.K., et al. A mutation in Rab27a causes the vesicle transport defects observed in ashen mice. Proceedings of the National Academy of Sciences of the United States of America 2000, 97:7933-7938.
133. Meschede I.P., Santos T.O., Izidoro-Toledo T.C., Gurgel-Gianetti J., Espreafico E.M. Griscelli syndrome-type 2 in twin siblings: case report and update on RAB27A human mutations and gene structure. Brazilian Journal Of Medical And Biological Research=Revista brasileira de pesquisas medicas e biologicas/Sociedade Brasileira de Biofisica [et al] 2008, 41:839-848.
134. Vincent L.M., Gilbert F., DiPace J.I., Ciccone C., Markello T.C., Jeong A., et al. Novel 47.5-kb deletion in RAB27A results in severe Griscelli syndrome Type 2. Molecular Genetics and Metabolism 2010, 101:62-65.
135. Anikster Y., Huizing M., Anderson P.D., Fitzpatrick D.L., Klar A., Gross-Kieselstein E., et al. Evidence that Griscelli syndrome with neurological involvement is caused by mutations in RAB27A, not MYO5A. American Journal of Human Genetics 2002, 71:407-414.
136. Bannasch D., Safra N., Young A., Karmi N., Schaible R.S., Ling G.V. Mutations in the SLC2A9 gene cause hyperuricosuria and hyperuricemia in the dog. PLoS Genetics 2008, 4:e1000246.
137. Kuklin A.I., Mynatt R.L., Klebig M.L., Kiefer L.L., Wilkison W.O., Woychik R.P., et al. Liver-specific expression of the agouti gene in transgenic mice promotes liver carcinogenesis in the absence of obesity and diabetes. Molecular Cancer 2004, 3:17.
138. Michaud E.J., Bultman S.J., Klebig M.L., van Vugt M.J., Stubbs L.J., Russell L.B., et al. A molecular model for the genetic and phenotypic characteristics of the mouse lethal yellow (Ay) mutation. Proceedings of the National Academy of Sciences of the United States of America 1994, 91:2562-2566.
139. Michaud E.J., Bultman S.J., Stubbs L.J., Woychik R.P. The embryonic lethality of homozygous lethal yellow mice (Ay/Ay) is associated with the disruption of a novel RNA-binding protein. Genes & Development 1993, 7:1203-1213.
140. Miller M.W., Duhl D.M., Vrieling H., Cordes S.P., Ollmann M.M., Winkes B.M., et al. Cloning of the mouse agouti gene predicts a secreted protein ubiquitously expressed in mice carrying the lethal yellow mutation. Genes & Development 1993, 7:454-467.
141. Miller M.W., Duhl D.M., Winkes B.M., Arredondo-Vega F., Saxon P.J., Wolff G.L., et al. The mouse lethal nonagouti (a(x)) mutation deletes the S-adenosylhomocysteine hydrolase (Ahcy) gene. The EMBO Journal 1994, 13:1806-1816.
142. Yen T.T., Gill A.M., Frigeri L.G., Barsh G.S., Wolff G.L. Obesity, diabetes, and neoplasia in yellow A(vy)/- mice: ectopic expression of the agouti gene. FASEB Journal 1994, 8:479-488.
143. Overton J.D., Leibel R.L. Mahoganoid and mahogany mutations rectify the obesity of the yellow mouse by effects on endosomal traffic of MC4R protein. The Journal of Biological Chemistry 2011, 286:18914-18929.
144. Miller K.A., Gunn T.M., Carrasquillo M.M., Lamoreux M.L., Galbraith D.B., Barsh G.S. Genetic studies of the mouse mutations mahogany and mahoganoid. Genetics 1997, 146:1407-1415.
145. Gunn T.M., Miller K.A., He L., Hyman R.W., Davis R.W., Azarani A., et al. The mouse mahogany locus encodes a transmembrane form of human attractin. Nature 1999, 398:152-156.
146. Matsushima Y., Shinkai Y., Kobayashi Y., Sakamoto M., Kunieda T., Tachibana M. A mouse model of Waardenburg syndrome type 4 with a new spontaneous mutation of the endothelin-B receptor gene. Mammalian Genome 2002, 13:30-35.
147. Geissler E.N., Russell E.S. Analysis of the hematopoietic effects of new dominant spotting (W) mutations of the mouse. I. Influence upon hematopoietic stem cells. Experimental Hematology 1983, 11:452-460.
148. Huang E.J., Manova K., Packer A.I., Sanchez S., Bachvarova R.F., Besmer P. The murine steel panda mutation affects kit ligand expression and growth of early ovarian follicles. Developmental Biology 1993, 157:100-109.
149. Rudelius M., Osanger A., Kohlmann S., Augustin M., Piontek G., Heinzmann U., et al. A missense mutation in the WD40 domain of murine Lyst is linked to severe progressive Purkinje cell degeneration. Acta Neuropathologica 2006, 112:267-276.
150. Runkel F., Bussow H., Seburn K.L., Cox G.A., Ward D.M., Kaplan J., et al. Grey, a novel mutation in the murine Lyst gene, causes the beige phenotype by skipping of exon 25. Mammalian Genome 2006, 17:203-210.
151. Morrone K., Wang Y., Huizing M., Sutton E., White J.G., Gahl W.A., et al. Two novel mutations identified in an African-American child with Chediak-Higashi syndrome. Case Reports in Medicine 2010, 2010:967535.
152. Zarzour W., Kleta R., Frangoul H., Suwannarat P., Jeong A., Kim S.Y., et al. Two novel CHS1 (LYST) mutations: clinical correlations in an infant with Chediak-Higashi syndrome. Molecular Genetics and Metabolism 2005, 85:125-132.
153. Cuajungco M.P., Samie M.A. The varitint-waddler mouse phenotypes and the TRPML3 ion channel mutation: cause and consequence. Pflugers Archiv: European Journal of Physiology 2008, 457:463-473.
154. Phan L.K., Chung W.K., Leibel R.L. The mahoganoid mutation (Mgrn1md) improves insulin sensitivity in mice with mutations in the melanocortin signaling pathway independently of effects on adiposity. American Journal of Physiology Endocrinology and Metabolism 2006, 291:E611-E620.
155. Philipp U., Lupp B., Momke S., Stein V., Tipold A., Eule J.C., et al. A MITF mutation associated with a dominant white phenotype and bilateral deafness in German Fleckvieh cattle. PLoS ONE 2011, 6:e28857.
156. Steingrimsson E., Copeland N.G., Jenkins N.A. Melanocytes and the microphthalmia transcription factor network. Annual Review of Genetics 2004, 38:365-411.
157. Yajima I., Sato S., Kimura T., Yasumoto K., Shibahara S., Goding C.R., et al. An L1 element intronic insertion in the black-eyed white (Mitf[mi-bw]) gene: the loss of a single Mitf isoform responsible for the pigmentary defect and inner ear deafness. Human Molecular Genetics 1999, 8:1431-1441.
158. Hansdottir A.G., Palsdottir K., Favor J., Neuhauser-Klaus A., Fuchs H., de Angelis M.H., et al. The novel mouse microphthalmia mutations Mitfmi-enu5 and Mitfmi-bcc2 produce dominant negative Mitf proteins. Genomics 2004, 83:932-935.
159. Huang J.D., Cope M.J., Mermall V., Strobel M.C., Kendrick-Jones J., Russell L.B., et al. Molecular genetic dissection of mouse unconventional myosin-VA: head region mutations. Genetics 1998, 148:1951-1961.
160. Huang J.D., Mermall V., Strobel M.C., Russell L.B., Mooseker M.S., Copeland N.G., et al. Molecular genetic dissection of mouse unconventional myosin-VA: tail region mutations. Genetics 1998, 148:1963-1972.
161. Gardner J.M., Nakatsu Y., Gondo Y., Lee S., Lyon M.F., King R.A., et al. The mouse pink-eyed dilution gene: association with human Prader-Willi and Angelman syndromes. Science 1992, 257:1121-1124.
162. Lyon M.F., King T.R., Gondo Y., Gardner J.M., Nakatsu Y., Eicher E.M., et al. Genetic and molecular analysis of recessive alleles at the pink-eyed dilution (p) locus of the mouse. Proceedings of the National Academy of Sciences of the United States of America 1992, 89:6968-6972.
163. Rinchik E.M., Bultman S.J., Horsthemke B., Lee S.T., Strunk K.M., Spritz R.A., et al. A gene for the mouse pink-eyed dilution locus and for human type II oculocutaneous albinism. Nature 1993, 361:72-76.
164. Mondal M., Sengupta M., Samanta S., Sil A., Ray K. Molecular basis of albinism in India: evaluation of seven potential candidate genes and some new findings. Gene 2012, 511:470-474.
165. Morell R., Friedman T.B., Moeljopawiro S., Hartono Soewito Asher J.H. A frameshift mutation in the HuP2 paired domain of the probable human homolog of murine Pax-3 is responsible for Waardenburg syndrome type 1 in an Indonesian family. Human Molecular Genetics 1992, 1:243-247.
166. Goulding M., Sterrer S., Fleming J., Balling R., Nadeau J., Moore K.J., et al. Analysis of the Pax-3 gene in the mouse mutant splotch. Genomics 1993, 17:355-363.
167. Vogan K.J., Epstein D.J., Trasler D.G., Gros P. The splotch-delayed (Spd) mouse mutant carries a point mutation within the paired box of the Pax-3 gene. Genomics 1993, 17:364-369.
168. Andersson L.S., Juras R., Ramsey D.T., Eason-Butler J., Ewart S., Cothran G., et al. Equine multiple congenital ocular anomalies maps to a 4.9 megabase interval on horse chromosome 6. BMC Genetics 2008, 9:88.
169. Jolly R.D., Wills J.L., Kenny J.E., Cahill J.I., Howe L. Coat-colour dilution and hypotrichosis in Hereford crossbred calves. New Zealand Veterinary Journal 2008, 56:74-77.
170. Menasche G., Feldmann J., Houdusse A., Desaymard C., Fischer A., Goud B., et al. Biochemical and functional characterization of Rab27a mutations occurring in Griscelli syndrome patients. Blood 2003, 101:2736-2742.
171. Oiso N., Riddle S.R., Serikawa T., Kuramoto T., Spritz R.A. The rat Ruby (R) locus is Rab38: identical mutations in Fawn-hooded and Tester-Moriyama rats derived from an ancestral Long Evans rat sub-strain. Mammalian Genome 2004, 15:307-314.
172. Inagaki K., Suzuki T., Shimizu H., Ishii N., Umezawa Y., Tada J., et al. Oculocutaneous albinism type 4 is one of the most common types of albinism in Japan. American Journal of Human Genetics 2004, 74:466-471.
173. Sanchez-Martin M., Rodriguez-Garcia A., Perez-Losada J., Sagrera A., Read A.P., Sanchez-Garcia I. SLUG (SNAI2) deletions in patients with Waardenburg disease. Human Molecular Genetics 2002, 11:3231-3236.
174. Perez-Losada J., Sanchez-Martin M., Rodriguez-Garcia A., Sanchez M.L., Orfao A., Flores T., et al. Zinc-finger transcription factor Slug contributes to the function of the stem cell factor c-kit signaling pathway. Blood 2002, 100:1274-1286.
175. Herbarth B., Pingault V., Bondurand N., Kuhlbrodt K., Hermans-Borgmeyer I., Puliti A., et al. Mutation of the Sry-related Sox10 gene in Dominant megacolon, a mouse model for human Hirschsprung disease. Proceedings of the National Academy of Sciences of the United States of America 1998, 95:5161-5165.
176. Southard-Smith E.M., Angrist M., Ellison J.S., Agarwala R., Baxevanis A.D., Chakravarti A., et al. The Sox10(Dom) mouse: modeling the genetic variation of Waardenburg-Shah (WS4) syndrome. Genome Research 1999, 9:215-225.
177. Pingault V., Bondurand N., Kuhlbrodt K., Goerich D.E., Prehu M.O., Puliti A., et al. SOX10 mutations in patients with Waardenburg-Hirschsprung disease. Nature Genetics 1998, 18:171-173.
178. Lee M., Goodall J., Verastegui C., Ballotti R., Goding C.R. Direct regulation of the Microphthalmia promoter by Sox10 links Waardenburg-Shah syndrome (WS4)-associated hypopigmentation and deafness to WS2. The Journal of Biological Chemistry 2000, 275:37978-37983.
179. Bellone R.R., Brooks S.A., Sandmeyer L., Murphy B.A., Forsyth G., Archer S., et al. Differential gene expression of TRPM1, the potential cause of congenital stationary night blindness and coat spotting patterns (LP) in the Appaloosa horse (Equus caballus). Genetics 2008, 179:1861-1870.
180. Tolmachova T., Wavre-Shapton S.T., Barnard A.R., MacLaren R.E., Futter C.E., Seabra M.C. Retinal pigment epithelium defects accelerate photoreceptor degeneration in cell type-specific knockout mouse models of choroideremia. Investigative Ophthalmology & Visual Science 2010, 51:4913-4920.